Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aduhelm
Pharma
More transparency, evidence needed for accelerated nods: ICER
The FDA should strengthen the evidence required for accelerated drug approvals and increase transparency surrounding those decisions, ICER says.
Kevin Dunleavy
Apr 17, 2026 11:22am
With trial looming, Biogen and investors settle Aduhelm claims
Apr 8, 2026 11:28am
Biogen slapped with DOJ subpoena over foreign operations
Feb 14, 2024 10:58am
Biogen drops Aduhelm efforts after ill-fated accelerated approval
Jan 31, 2024 8:35am
A look at FDA's Aduhelm approval and regulatory bias
Oct 27, 2023 8:00am
Appeals court revives part of Biogen investor lawsuit
Oct 12, 2023 3:42pm
